MARKET

ACON

ACON

Aclarion Inc
NASDAQ
3.110
+0.010
+0.33%
Opening 12:25 05/12 EDT
OPEN
3.160
PREV CLOSE
3.100
HIGH
3.190
LOW
3.110
VOLUME
33.88K
TURNOVER
--
52 WEEK HIGH
12.03
52 WEEK LOW
2.340
MARKET CAP
7.66M
P/E (TTM)
-0.2285
1D
5D
1M
3M
1Y
5Y
1D
Aclarion director David K. Neal acquires 2,500 common shares worth $7,750
PUBT · 4h ago
Top Executive Makes Bold Insider Move at Aclarion, Inc.
TipRanks · 14h ago
Weekly Report: what happened at ACON last week (0504-0508)?
Weekly Report · 1d ago
Aclarion director William Wesemann acquires 1,562 common shares for $5,154.6
PUBT · 3d ago
Aclarion Adds Lanman Spinal Neurosurgery As Clinical Site In CLARITY Trial
Benzinga · 5d ago
ACLARION INC - EXPECTS PUBLIC DISCLOSURE OF EARLY INTERIM CLARITY TRIAL RESULTS IN Q4 2026
Reuters · 5d ago
ACLARION ANNOUNCES ADDITION OF FIRST PRIVATE PRACTICE SITE IN LOS ANGELES INTO CLARITY TRIAL TO FURTHER ACCELERATE ENROLLMENT
Reuters · 5d ago
Aclarion grants new Western US commercial director option for 17,000 shares at $3.2
PUBT · 6d ago
More
About ACON
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.

Webull offers Aclarion Inc stock information, including NASDAQ: ACON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACON stock methods without spending real money on the virtual paper trading platform.